Copenhagen Prospective Personalized Oncology (CoPPO)—impact of comprehensive genomic profiling in more than 2000 patients in a phase I setting. - Belcaid, L.; Højgaard, M.; Tuxen, I.; Spanggaard, I.; Lassen, U.; Robinson, L.; Rossing, M.; Bagger, F.; Ahlborn, L.B.; Schmidt, A.Y.; Hasselby, J.P.; Santoni-Rugiu, E.; et al. (Annals of Oncology, 2025)